This inventor holds 1 USPTO granted patent. Top assignee: Bionutrigen Co., Ltd.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Hee-Sook Jeon: Innovator in Anti-Diabetic Agents
Introduction: Hee-Sook Jeon is a notable inventor based in Lake Bluff, IL (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that can aid in the management of diabetes. His innovative work has led to the creation of a unique derivative that has potential therapeutic applications.
Latest Patents: Hee-Sook Jeon holds 1 patent for a novel 3,4-dihydroxyhydrocinnamic acid derivative, designated DHH105. This compound has been shown to have blood glucose-lowering effects in vivo, achieved through the enhancement of glucose transport mediated by increased insulin receptor signaling. The invention is particularly relevant as it offers a new approach to anti-diabetic agents.
Career Highlights: Throughout his career, Hee-Sook Jeon has focused on the intersection of chemistry and health, striving to create solutions that address critical health issues. His work at Bionutrigen Co., Ltd. has positioned him as a key player in the development of innovative health products.
Collaborations: Hee-Sook Jeon has worked alongside talented colleagues, including Eun-Eai Kim and Wi Kim, contributing to a collaborative environment that fosters innovation and creativity.
Conclusion: Hee-Sook Jeon's contributions to the field of anti-diabetic agents exemplify the impact of innovative research on public health. His work continues to inspire advancements in medicinal chemistry and diabetes management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile